Advertisement
Advertisement
U.S. markets close in 2 hours 48 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.5550-0.0233 (-4.03%)
As of 01:11PM EDT. Market open.
Advertisement
Sign in to post a message.
  • e
    eric
    Soooo oversold
  • A
    Andy
    Whether the market is green or red there is no interest in this company and stock.
  • R
    Ray
    There was some nice buying around .62 ~.63 this morning. Should continue to move up, someone is buying some decent size blocks.
    Bullish
  • R
    Ray
    Next resistance is around .72 .73, look at the charts and volume. Something is up on a positive note.
    Bullish
  • C
    Clint
    Going run… load up!
  • R
    Rafa
    It’s pretty amazing that Orchard has been beaten down to the $.40s. They have not at all been rewarded for their accomplishments to date. We all realize that MLD is a very rare desease and may never provide the revenue to turn Orchard into a great investment. But Limeldy works and it may provide a normal life for very young kids suffering from MLD. Hopefully more countries approve its use and provide the reimbursement necessary for Orchard to continue.
    The big question becomes can Orchard utilize their stem cell knowledge on more common indications such as Crones and Dementia. They certainly explain HSC’s mechanism of action in great detail. Certainly Orchard’s management believes HSC will crossover as does RA Capital, Federated Hermes and FMR. They have enough cash to get us into 2024 to find out. It looks like a great bet!! Thoughts?
  • j
    joe
    Barklays lowered their price target to $4.00 for this junk. If it ever went that high I would still have lost 50% of my investment.
  • w
    wallstboss
    (ADIL) $1.22 --MCap $29 mil --- Blockbuster Phase 3 results imminent ( in June) = $$$$$$$$$$$$$$$$
    "Nears completion of ONWARD™ Phase 3 pivotal trial of AD04 for the treatment of
    Alcohol Use Disorder; on track to report Phase 3 results in the current quarter"

    #+#+
  • C
    Clint
    Just bought in last week. .45c is awful cheap for a market cap of $ 58m with 200m in hand and a debt tranche of 33m coming in November. Should pop 200-400% on a XBI recovery!
  • A
    Asyan
    Halloo, any news please?
  • A
    Andy
    $5.50 down to 44 cents in one yr. UFB.
  • P
    Paul B
    i used to be kidding when I said this #$%$ was going to $.00 Might happen!
  • R
    Ross Perot
    Shut the doors and distribute the cash and IP...this would instantly quadruple
  • Y
    Yahoo Finance Insights
    Orchard Therapeutics is down 11.47% to 0.45
  • C
    Charlie
    Where are the pumpers ??? Backing this #$%$ to buy and buy and buy.
    Bearish
  • Y
    Yahoo Finance Insights
    Orchard Therapeutics reached a 52 Week low at 0.49
  • T
    Tony
    The FDA has granted Orchard Therapeutics' (NASDAQ:ORTX) OTL-200 its Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of early-onset metachromatic leukodystrophy (MLD), a rare hereditary disorder characterised by accumulation of fats called sulfatides.
    Bullish
  • K
    Kyle
    Data is out. Positive results as far as I’m reading. Tons of info on Tekada and Denali, among many others. Really good stuff. If you have a college email you can access the info through the conference website. Take a gander.
  • T
    Thomas
    JPM`s 5-star analyst give a "strong bye". $15!
    Bullish
  • R
    Raul
    I think after the February 9th presentation it could go a few dollars up probably $9? Hopefully..
    Bullish
Advertisement
Advertisement